{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T10:26:13Z","timestamp":1780655173600,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fondo de Investigaci\u00f3n Sanitaria of the Instituto de Salud Carlos III","award":["PI20\/01223"],"award-info":[{"award-number":["PI20\/01223"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11596-w","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:53:54Z","timestamp":1761044034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Real world effectiveness of antipneumococcal vaccination against pneumonia in adults: a population-based cohort study, Catalonia, 2019"],"prefix":"10.1186","volume":"25","author":[{"given":"Cinta","family":"de Diego-Cabanes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f2nica","family":"Torras-Vives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Vila-C\u00f3rcoles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Satu\u00e9-Gracia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jos\u00e9","family":"Forcadell-Peris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"G\u00f3mez-Bertomeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"de Esteban-J\u00falvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imma","family":"Hospital-Guardiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cruz M.","family":"Fuentes-Bellido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ribes-Alcover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Rodriguez-Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Ochoa-Gondar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"11596_CR1","doi-asserted-by":"publisher","first-page":"1028525","DOI":"10.3389\/fpubh.2022.1028525","volume":"10","author":"S Safiri","year":"2023","unstructured":"Safiri S, Mahmoodpoor A, Kolahi AA, Nejadghaderi SA, Sullman MJM, Mansournia MA, et al. Global burden of lower respiratory infections during the last three decades. Front Public Health. 2023;10:1028525.","journal-title":"Front Public Health"},{"key":"11596_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.rmed.2018.02.007","volume":"137","author":"A Torres","year":"2018","unstructured":"Torres A, Cill\u00f3niz C, Blasi F, Chalmers JD, Gaillat J, Dartois N, et al. Burden of pneumococcal community-acquired pneumonia in adults across Europe: a literature review. Respir Med. 2018;137:6\u201313. https:\/\/doi.org\/10.1016\/j.rmed.2018.02.007.","journal-title":"Respir Med"},{"key":"11596_CR3","first-page":"1","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","unstructured":"Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep. 1997;46:1\u201324.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"11596_CR4","first-page":"816","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","unstructured":"Centers for Disease Control and Prevention. Use of 13-valent Pneumococcal conjugate vaccine and 23-valent Pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012;61:816\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"11596_CR5","first-page":"822","volume":"63","author":"Centers for Disease Control and Prevention","year":"2014","unstructured":"Centers for Disease Control and Prevention. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged\u2009\u2265\u200965 years: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63:822\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"11596_CR6","first-page":"CD000422","volume":"1","author":"S Moberley","year":"2013","unstructured":"Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing Pneumococcal infections in adults (review). Cochrane Database Syst Rev. 2013;1:CD000422.","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"11596_CR7","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","volume":"372","author":"MJ Bonten","year":"2015","unstructured":"Bonten MJ, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015;372(12):1114\u201325. https:\/\/doi.org\/10.1056\/NEJMoa1408544.","journal-title":"N Engl J Med"},{"issue":"1","key":"11596_CR8","doi-asserted-by":"publisher","first-page":"e0169368","DOI":"10.1371\/journal.pone.0169368","volume":"12","author":"G Falkenhorst","year":"2017","unstructured":"Falkenhorst G, Remschmidt C, Harder T, Hummers-Pradier E, Wichmann O, Bogdan C. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPV23) against pneumococcal disease in the elderly: systematic review and meta-analysis. PLoS One. 2017;12(1):e0169368. https:\/\/doi.org\/10.1371\/journal.pone.0169368.","journal-title":"PLoS One"},{"issue":"1","key":"11596_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146338","volume":"11","author":"J Schiffner-Rohe","year":"2016","unstructured":"Schiffner-Rohe J, Witt A, Hemmerling J, von Eiff C, Leverkus FW. Efficacy of PPV23 in preventing pneumococcal pneumonia in adults at increased risk\u2013a systematic review and meta-analysis. PLoS One. 2016;11(1):e0146338. https:\/\/doi.org\/10.1371\/journal.pone.0146338.","journal-title":"PLoS One"},{"issue":"5","key":"11596_CR10","doi-asserted-by":"publisher","first-page":"e0177985","DOI":"10.1371\/journal.pone.0177985","volume":"12","author":"M Tin Tin Htar","year":"2017","unstructured":"Tin Tin Htar M, Stuurman AL, Ferreira G, Alicino C, Bollaerts K, Paganino C, et al. Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies. PLoS One. 2017;12(5):e0177985. https:\/\/doi.org\/10.1371\/journal.pone.0177985.","journal-title":"PLoS One"},{"issue":"4","key":"11596_CR11","doi-asserted-by":"publisher","first-page":"e0175224","DOI":"10.1371\/journal.pone.0175224","volume":"12","author":"J C\u00e0mara","year":"2017","unstructured":"C\u00e0mara J, Marim\u00f3n JM, Cercenado E, Larrosa N, Quesada MD, Fontanals D, et al. Decrease of invasive Pneumococcal disease (IPD) in adults after introduction of Pneumococcal 13-valent conjugate vaccine in Spain. PLoS ONE. 2017;12(4):e0175224. https:\/\/doi.org\/10.1371\/journal.pone.0175224.","journal-title":"PLoS ONE"},{"issue":"5","key":"11596_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","volume":"15","author":"PA Waight","year":"2015","unstructured":"Waight PA, Andrews NJ, Ladhani SN, Sheppard CL, Slack MP, Miller E. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis. 2015;15(5):535\u201343.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"11596_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/thoraxjnl-2018-211767","volume":"74","author":"G Hanquet","year":"2019","unstructured":"Hanquet G, Krizova P, Valentiner-Branth P, Ladhani SN, Nuorti JP, Lepoutre A, et al. Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination. Thorax. 2019;74(5):473\u201382. https:\/\/doi.org\/10.1136\/thoraxjnl-2018-211767.","journal-title":"Thorax"},{"issue":"4","key":"11596_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9040259","volume":"9","author":"JD Berild","year":"2020","unstructured":"Berild JD, Winje BA, Vestrheim DF, Slotved HC, Valentiner-Branth P, Roth A, et al. Systematic review of studies published between 2016 and 2019 on the effectiveness and efficacy of pneumococcal vaccination on pneumonia and invasive pneumococcal disease in an elderly population. Pathogens. 2020;9(4):259. https:\/\/doi.org\/10.3390\/pathogens9040259.","journal-title":"Pathogens"},{"issue":"9","key":"11596_CR15","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s40273-019-00805-5","volume":"37","author":"M Treskova","year":"2019","unstructured":"Treskova M, Scholz SM, Kuhlmann A. Cost effectiveness of elderly pneumococcal vaccination in presence of higher-valent pneumococcal conjugate childhood vaccination: systematic literature review with focus on methods and assumptions. Pharmacoeconomics. 2019;37(9):1093\u2013127. https:\/\/doi.org\/10.1007\/s40273-019-00805-5.","journal-title":"Pharmacoeconomics"},{"issue":"46","key":"11596_CR16","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.15585\/mmwr.mm6846a5","volume":"68","author":"A Matanock","year":"2019","unstructured":"Matanock A, Lee G, Gierke R, Kobayashi M, Leidner A, Pilishvili T. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged\u2009\u2265\u200965 years: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2019;68(46):1069\u201375. https:\/\/doi.org\/10.15585\/mmwr.mm6846a5.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"11596_CR17","unstructured":"CDC, Pneumococcal Vaccination. Summary of Who and When to Vaccinate. Centers for Disease Control and Prevention. CDC; 2024. Accessed 2025 April 30. https:\/\/www.cdc.gov\/vaccines\/vpd\/pneumo\/hcp\/who-when-to-vaccinate.html"},{"key":"11596_CR18","doi-asserted-by":"publisher","unstructured":"Kobayashi M, Leidner AJ, Gierke R et al. Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024. MMWR Morb Mortal Wkly Rep. 2024;73:793\u201398.\u00a0https:\/\/doi.org\/10.15585\/mmwr.mm7336a3.","DOI":"10.15585\/mmwr.mm7336a3"},{"issue":"4","key":"11596_CR19","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10096-019-03485-3","volume":"38","author":"C Bonnave","year":"2019","unstructured":"Bonnave C, Mertens D, Peetermans W, Cobbaert K, Ghesquiere B, Deschodt M, et al. Adult vaccination for pneumococcal disease: a comparison of the National guidelines in Europe. Eur J Clin Microbiol Infect Dis. 2019;38(4):785\u201391. https:\/\/doi.org\/10.1007\/s10096-019-03485-3.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"11596_CR20","unstructured":"European Centre for Disease Prevention and Control. (2024). Vaccine Scheduler: Pneumococcal Disease. Retrieved November 25, 2024, from https:\/\/www.ecdc.europa.eu\/en\/publications-data\/ecdc-vaccine-scheduler"},{"key":"11596_CR21","unstructured":"Generalitat de Catalunya. Calendari de vacunacions sistematiques 2016. Barcelona (SP): Generalitat de Catalunya. Departament de Salut; 2017 [accessed 2025 April 11]. https:\/\/canalsalut.gencat.cat\/ca\/salut-a-z\/v\/vacunacions\/calendari\/"},{"key":"11596_CR22","doi-asserted-by":"publisher","first-page":"100264","DOI":"10.1016\/j.jvacx.2023.100264","volume":"13","author":"A Vila-C\u00f3rcoles","year":"2023","unstructured":"Vila-C\u00f3rcoles A, Ochoa-Gondar O, de Diego-Cabanes C, Satu\u00e9-Gracia EM, Torras-Vives V, Forcadell-Peris MJ, et al. Evaluating clinical effectiveness and impact of anti-pneumococcal vaccination in adults after universal childhood PCV13 implementation in Catalonia, 2017\u20132018. Vaccine X. 2023;13:100264. https:\/\/doi.org\/10.1016\/j.jvacx.2023.100264.","journal-title":"Vaccine X"},{"key":"11596_CR23","unstructured":"WMA Declaration of Helsinki \u2013 Ethical Principles for Medical Research Involving Human Subjects. World Medical Association. 2018 Jul 09 [accessed 2025 April 03]. https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/"},{"issue":"3","key":"11596_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.14236\/jhi.v19i3.806","volume":"19","author":"M Garc\u00eda-Gil Mdel","year":"2011","unstructured":"Garc\u00eda-Gil Mdel M, Hermosilla E, Prieto-Alhambra D, Fina F, Rosell M, Ramos R, et al. Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP). Inf Prim Care. 2011;19(3):135\u201345. https:\/\/doi.org\/10.14236\/jhi.v19i3.806.","journal-title":"Inf Prim Care"},{"key":"11596_CR25","unstructured":"Ministerio de Sanidad. Conjunto M\u00ednimo B\u00e1sico de Datos de Hospitalizaci\u00f3n (CMBD-H). Madrid: Ministerio de Sanidad. Portal estad\u00edstico. \u00c1rea de inteligencia de gesti\u00f3n [accessed 2025 April 11]. https:\/\/pestadistico.inteligenciadegestion.sanidad.gob.es\/publicoSNS\/N\/rae-cmbd\/cmbd-h"},{"issue":"1","key":"11596_CR26","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12879-018-3096-7","volume":"18","author":"A Vila-Corcoles","year":"2018","unstructured":"Vila-Corcoles A, Ochoa-Gondar O, de Diego C, Satue E, Arag\u00f3n M, Vila-Rovira A, et al. Evaluating clinical effectiveness of 13-valent Pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study. BMC Infect Dis. 2018;18(1):196. https:\/\/doi.org\/10.1186\/s12879-018-3096-7.","journal-title":"BMC Infect Dis"},{"key":"11596_CR27","doi-asserted-by":"publisher","unstructured":"Torres A, Barber\u00e1n J, Falguera M, Men\u00e9ndez R, Molina J, Olaechea P et al. Multidisciplinary guidelines for the management of community-acquired pneumonia [in Spanish]. Med Clin (Barc). 2013;140(5):223.e1-223.e19. Spanish. https:\/\/doi.org\/10.1016\/j.medcli.2012.09.034","DOI":"10.1016\/j.medcli.2012.09.034"},{"key":"11596_CR28","volume-title":"Applied survival analysis. Regression modeling of time to event data","author":"DW Hosmer","year":"1999","unstructured":"Hosmer DW, Lemeshow S. Applied survival analysis. Regression modeling of time to event data. New York: Wiley; 1999."},{"key":"11596_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jclinepi.2009.03.001","volume":"63","author":"JLF Bosco","year":"2010","unstructured":"Bosco JLF, Silliman RA, Thwin SS, Geiger AM, Buist DSM, Prout MN, et al. A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol. 2010;63:64\u201374.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"11596_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12050732","volume":"12","author":"JL Farrar","year":"2023","unstructured":"Farrar JL, Childs L, Ouattara M, Akhter F, Britton A, Pilishvili T, et al. Systematic review and meta- analysis of the efficacy and effectiveness of Pneumococcal vaccines in adults. Pathogens. 2023;12(5):732. https:\/\/doi.org\/10.3390\/pathogens12050732.","journal-title":"Pathogens"},{"issue":"1","key":"11596_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1001\/jamainternmed.2022.5472","volume":"183","author":"M Kobayashi","year":"2023","unstructured":"Kobayashi M, Spiller MW, Wu X, Wang R, Chillarige Y, Wernecke M, et al. Association of pneumococcal conjugate vaccine use with hospitalized pneumonia in medicare beneficiaries 65 years or older with and without medical conditions, 2014 to 2017. JAMA Intern Med. 2023;183(1):40\u20137. https:\/\/doi.org\/10.1001\/jamainternmed.2022.5472.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"11596_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.mm7401a1","volume":"74","author":"M Kobayashi","year":"2025","unstructured":"Kobayashi M, Leidner AJ, Gierke R, Xing W, Accorsi E, Moro P, et al. Recommendations for use of Pneumococcal conjugate vaccines among adults aged\u2009\u2265\u200950 years: recommendations of the advisory committee on immunization Practices - United states, 2024. MMWR Morb Mortal Wkly Rep. 2025;74(1):1\u20138. https:\/\/doi.org\/10.15585\/mmwr.mm7401a1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"11596_CR33","doi-asserted-by":"publisher","unstructured":"Torras-Vives V, de Diego-Cabanes C, Satu\u00e9-Gracia EM, Forcadell-Peris MJ, Ochoa-Gondar O, Vila-C\u00f3rcoles \u00c1. Incidence of Pneumococcal and all-cause pneumonia in adults in Catalonia following the implementation of universal Pneumococcal vaccination in children: 2015\u20132016 vs. 2017\u20132018. Enferm infecc microbiol clin (Engl Ed). Published Online March. 2025;28. https:\/\/doi.org\/10.1016\/j.eimce.2025.03.005.","DOI":"10.1016\/j.eimce.2025.03.005"},{"key":"11596_CR34","unstructured":"Ardanuy C, Broner S, Cabezas C, Ciruela P, Izquierdo C, Mart\u00ednez M et al. Epidemiolog\u00eda de la enfermedad neumoc\u00f3cica invasiva en Catalu\u00f1a: informe 2021\u20132022; sistema de notificaci\u00f3n microbiol\u00f3gica de Catalu\u00f1a. Barcelona: Ag\u00e8ncia de Salut P\u00fablica de Catalunya; 2023. Available at: https:\/\/saludpublica.gencat.cat\/web\/.content\/minisite\/aspcat\/vigilancia_salud_publica\/SNMC\/epidemiologia-malalties-snmc\/epidemiologia-de-la-malaltia-pneumoccica-invasiva-a-Catalunya.-Informe-2019-2020.pdf [accessed: 2025 March 09]."},{"issue":"3","key":"11596_CR35","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.eimc.2020.02.016","volume":"39","author":"JM Marimon","year":"2021","unstructured":"Marimon JM, Ardanuy C. Epidemiology of pneumococcal diseases in Spain after the introduction of pneumococcal conjugate vaccines. Enferm Infecc Microbiol Clin (Engl Ed). 2021;39(3):142\u201350. https:\/\/doi.org\/10.1016\/j.eimc.2020.02.016.","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"issue":"1","key":"11596_CR36","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2328963","volume":"20","author":"K Nakashima","year":"2024","unstructured":"Nakashima K, Fukushima W. Strategies for pneumococcal vaccination in older adults in the coming era. Hum Vaccin Immunother. 2024;20(1):2328963. https:\/\/doi.org\/10.1080\/21645515.2024.2328963.","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"11596_CR37","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41579-024-01116-z","volume":"23","author":"AR Narciso","year":"2025","unstructured":"Narciso AR, Dookie R, Nannapaneni P, Normark S, Henriques-Normark B. Streptococcus pneumoniae epidemiology, pathogenesis and control. Nat Rev Microbiol. 2025;23(4):256\u201371. https:\/\/doi.org\/10.1038\/s41579-024-01116-z.","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"11596_CR38","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/QCO.0000000000001005","volume":"37","author":"C Elias","year":"2024","unstructured":"Elias C, Nunes MC, Saadatian-Elahi M. Epidemiology of community-acquired pneumonia caused by Streptococcus pneumoniae in older adults: a narrative review. Curr Opin Infect Dis. 2024;37(2):144\u201353.","journal-title":"Curr Opin Infect Dis"},{"issue":"10","key":"11596_CR39","doi-asserted-by":"publisher","first-page":"e0275642","DOI":"10.1371\/journal.pone.0275642","volume":"17","author":"AJ Streeter","year":"2022","unstructured":"Streeter AJ, Rodgers LR, Masoli J, Lin NX, Bl\u00e9 A, Hamilton W, et al. Real-world effectiveness of Pneumococcal vaccination in older adults: cohort study using the UK clinical practice research datalink. PLoS ONE. 2022;17(10):e0275642. https:\/\/doi.org\/10.1371\/journal.pone.0275642.","journal-title":"PLoS ONE"},{"key":"11596_CR40","unstructured":"Generalitat de Catalunya. Population on 1 January. By age group. Catalunya: Statistical Institute of Catalonia. Annual indicators. Demography\u2022Society. Population figures. 2021 [accessed: 2025 April 11] https:\/\/www.idescat.cat\/indicadors\/?id=anuals%26;n=10329%26;col=1\u27e8=en"},{"issue":"3","key":"11596_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.arbres.2022.12.015","volume":"59","author":"EM Dunne","year":"2023","unstructured":"Dunne EM, Cilloniz C, von Mollendorf C, Lewnard J, Grant LR, Slack MPE, et al. Pneumococcal vaccination in adults: what can we learn from observational studies that evaluated PCV13 and PPV23 effectiveness in the same population?? Arch Bronconeumol. 2023;59(3):157\u201364. https:\/\/doi.org\/10.1016\/j.arbres.2022.12.015.","journal-title":"Arch Bronconeumol"},{"issue":"3","key":"11596_CR42","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/oxfordjournals.aje.a009804","volume":"149","author":"RE Guevara","year":"1999","unstructured":"Guevara RE, Butler JC, Marston BJ, Plouffe JF, File TM Jr, Breiman RF. Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. Am J Epidemiol. 1999;149(3):282\u20139. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a009804.","journal-title":"Am J Epidemiol"},{"key":"11596_CR43","unstructured":"Ciruela P, Broner S, Izquierdo C, Nogueras MM, Hern\u00e1ndez S, Mu\u00f1oz-Almagro C et al. Epidemiolog\u00eda de la enfermedad neumoc\u00f3cica invasiva en Catalu\u00f1a. Informe 2017\u20132018. Barcelona: Agencia de Salud P\u00fablica de Catalu\u00f1a. Departamento de Salud; 2020 [accessed 2025 April. 11]. https:\/\/scientiasalut.gencat.cat\/bitstream\/handle\/11351\/5457\/epidemiologia_malaltia_pneumococcica_catalunya_2017_2018_cas.pdf?sequence=5"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11596-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11596-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11596-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:05:22Z","timestamp":1761087922000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11596-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11596"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11596-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were performed in accordance with relevant guidelines and regulations. The study was approved by the Ethics Committee of the Institution (\n                      Institut d\u2019Investigaci\u00f3 Atenci\u00f3 Prim\u00e0ria\n                      [IDIAP] Jordi Gol, file P14\/134;\n                      Institut Catal\u00e0 de la Salut\n                      ; Barcelona) and was conducted in accordance with the general principles for observational studies. The need for informed consent was waived by the Ethics Committee of the Institution due to the nature of the data (pseudonymised) and according to the European General Regulation for Data Protection, RGDP, article 6.e, 9.2.j and 89. The present study was carried out in full compliance with the ethical principles established by the Declaration of Helsinki, including its later amendments. Furthermore, the study followed the guidelines for good research practices, specifically those concerning observational studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1369"}}